SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $313 | -9.3% | 11,348 | -1.2% | 0.00% | 0.0% |
Q2 2023 | $345 | -8.5% | 11,484 | +10.3% | 0.00% | -50.0% |
Q1 2023 | $377 | +4.1% | 10,416 | +2.6% | 0.00% | 0.0% |
Q4 2022 | $362 | -99.9% | 10,153 | -20.2% | 0.00% | -33.3% |
Q3 2022 | $431,000 | +22.1% | 12,724 | +4.2% | 0.00% | +50.0% |
Q2 2022 | $353,000 | -10.4% | 12,214 | +0.3% | 0.00% | 0.0% |
Q1 2022 | $394,000 | +37.3% | 12,182 | +23.8% | 0.00% | 0.0% |
Q4 2021 | $287,000 | +13.0% | 9,840 | +3.3% | 0.00% | 0.0% |
Q3 2021 | $254,000 | -16.2% | 9,525 | -3.2% | 0.00% | 0.0% |
Q2 2021 | $303,000 | – | 9,837 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |